These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7749833)

  • 1. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.
    Notarbartolo A; Davì G; Averna M; Barbagallo CM; Ganci A; Giammarresi C; La Placa FP; Patrono C
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):247-51. PubMed ID: 7749833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
    Davì G; Averna M; Catalano I; Barbagallo C; Ganci A; Notarbartolo A; Ciabattoni G; Patrono C
    Circulation; 1992 May; 85(5):1792-8. PubMed ID: 1572035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia.
    Davì G; Ganci A; Averna M; Giammarresi C; Barbagallo C; Catalano I; Calà A; Notarbartolo A
    Thromb Haemost; 1995 Oct; 74(4):1015-9. PubMed ID: 8560403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia.
    Bröijersén A; Eriksson M; Leijd B; Angelin B; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):273-8. PubMed ID: 9081681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M; Bonnefous F; Debbas N; Irvine A
    Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
    Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
    Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients.
    Davì G; Averna M; Novo S; Barbagallo CM; Mogavero A; Notarbartolo A; Strano A
    Atherosclerosis; 1989 Sep; 79(1):79-83. PubMed ID: 2803348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
    Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
    Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E; Truffert J; De Gennes JL
    Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
    Davì G; Gresele P; Violi F; Basili S; Catalano M; Giammarresi C; Volpato R; Nenci GG; Ciabattoni G; Patrono C
    Circulation; 1997 Jul; 96(1):69-75. PubMed ID: 9236419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
    Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
    Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study.
    Yoshida H; Ishikawa T; Ayaori M; Shige H; Hosoai H; Nishio E; Tomiyasu K; Yamashita T; Suzukawa M; Nishiwaki M
    Clin Ther; 1995; 17(3):379-89. PubMed ID: 7585842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M; Eriksson LO; Germershausen JI; Thysell H
    Nephron; 1994; 68(1):57-62. PubMed ID: 7991041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response of simvastatin in primary hypercholesterolemia.
    Tuomilehto J; Guimaraes AC; Kettner H; Lithell H; Pitkänen M; Sailer D; Van Gaal LF
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):941-9. PubMed ID: 7898078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
    Lintott CJ; Scott RS; Sutherland WH; Bremer J
    Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.